In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law